4884.T
Kringle Pharma,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 559.00
−3.29%Year over year
Reported trailing growth
- Revenue
- +1.4%
- EBITDA
- —
- EBIT
- +5.1%
- EPS
- +4.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +354.8%
- EBITDA
- —
- EPS
- -6.6%
Three-year CAGR
- Revenue
- -43.1%
- EBITDA
- —
- EBIT
- -11.3%
- Net income
- -21.2%
- EPS
- -13.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026